Navigation Links
Signaling protein helps limit damage in heart attack, Jefferson scientists show
Date:3/21/2008

(PHILADELPHIA) Scientists at the Center for Translational Medicine at Thomas Jefferson University in Philadelphia have shown that a specific signaling protein is crucial to protecting the heart and helping it to adapt during a heart attack.

The protein Gi is known to have increased activity in the failing heart, but researchers have never been sure if it was helping the heart adapt to damage or if it was actually causing more heart cells to die. The Jefferson team, led by Walter Koch, Ph.D., W.W. Smith Professor of Medicine and director of the Center for Translational Medicine in the Department of Medicine at Jefferson Medical College, experimentally blocked the protein in the hearts of genetically engineered mice experiencing heart attacks. They found that the animals had greater heart damage than did similar mice with a working protein. The team reports its findings March 18, 2008, in the journal Circulation.

Gi is important in intracellular signaling, akin to a molecular switch, Dr. Koch notes. Its not a new drug target, he explains, but the activation of some receptors (such as beta-2 adrenergic receptors) that also turn on Gi could be targets.

Developing a class-specific Gi inhibitor, Dr. Koch explains, is an important step to understanding Gis role and behavior. We dont have to worry about what receptor we are blocking; were blocking a receptor that couples with Gi. We never had the tools before to tell if Gi activation was good or bad. We think that we can now begin to test the role of Gi in cardiac injury.

In the work, Dr. Kochs group developed a transgenic mouse with a functional knockout of the Gi gene, meaning that it lacked a working gene. The scientists then simulated a heart attack, catheterization and reperfusion by tieing off a coronary artery for 30 minutes and subsequently reestablishing the blood flow, causing an inflammatory response and tissue damage.

It appears that in this setting, Gi is an important protective mechanism, Dr. Koch says. The heart wants to activate Gi and attempt to protect cardiac myocytes from dying. We found that in this acute setting, heart attacks are bigger when Gi is blocked. As a result, the heart cant pump as well.

They would like to find out Gis role in chronic heart failure, where there is much less cell death occurring, and Gi levels remain high. In the chronic phase, Dr. Koch points out, Gi activity could be maladaptive. They plan to test the idea in chronic heart failure animal models.


'/>"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Related medicine news :

1. Emory researchers identify signaling protein for multiple myeloma
2. Cooper Clinic at Craig Ranch Opens Signaling the Next Phase of CooperLife Health-Focused Residential Community in McKinney
3. Scientists shed light on long-distance signaling in developing neurons
4. St. Jude finds signaling system that halts the growth of a childhood brain cancer
5. Draining away brains toxic protein to stop Alzheimers
6. Penn study finds pro-death proteins required to regulate healthy immune function
7. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
8. Human C-reactive protein regulates myeloma tumor cell growth and survival
9. Lowering Blood Protein Wont Help Kidney Patients
10. Blood protein detects lung cancer, even at earliest stage
11. Natural Protein Could Help Spot, Treat Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs ... properties including its unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) ... Nothing Water has been available in several ShopRite and FoodTown stores in NJ and ...
(Date:12/2/2016)... Abilene, Texas (PRWEB) , ... December 02, 2016 , ... ... article that delves into how this current generation fits into Bible Prophecy. Yisrayl says ... lists various facts pointing to this conclusion, showing how the details line up exactly ...
(Date:12/2/2016)... Francisco, CA (PRWEB) , ... December 02, 2016 ... ... digitally-enabled care journeys, announced today that it has raised $6.0 million in an ... inspired by Clarify Health’s conviction that patients and their caregivers can receive far ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today CloudMine, a secure, ... was named the best Sales Team of 2016 as part of the 2016 ... by the Software & Information Industry Association (SIIA), the principal trade association for ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for ... $1,000 each from the National Family Partnership and the Drug Enforcement Administration as part ... their homes and the 10 winning schools who decorated their campuses with this year’s ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  The Addiction Treatment Advisory ... of Managed Care Pharmacy (AMCP), has released detailed ... address the opioid addiction crisis, including through improved ... ATAG,s newly released paper, "The Role ... Naloxone," addresses many issues around gaps and barriers ...
(Date:12/2/2016)... 2016 CVS Health Corporation (NYSE: ... York City on Thursday, December 15, 2016, beginning at 8:00 a.m. (ET). ... provide an in-depth review of the company,s strategies to ... will also discuss 2017 earnings guidance during the event. ... event will be broadcast simultaneously on the Investor Relations ...
(Date:12/2/2016)... 2, 2016   CytoSorbents Corporation (NASDAQ: ... European Union approved CytoSorb ® cytokine adsorber to ... worldwide, announced that Dr. Phillip Chan , Chief ... LD Micro Main Event investor conference held from ... Luxe Sunset Boulevard Hotel in Los Angeles, ...
Breaking Medicine Technology: